Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INCWST · Entity 3201 | SVP, Glob Ops and Supply Chain | February 22, 2022 | February 25, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
WEST PHARMACEUTICAL SERVICES INC
Report date February 22, 2022 · Filed February 25, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 13,731.42 |
Reported balance
After 2022-02-22 transaction · row 1
1 source rowRow 1 · 2022-02-22 · Grant · Acquired 3,597 · Balance 13,731.42 F1: 2019 PSUs (PP18) award vesting net of taxes withheld. The net shares were deferred as deferred stock units in the Non-Qualified Deferred Compensation (NQDC) plan for employees to be distributed in accordance with the terms of the NQDC plan and their individual elections |
Filing footnotes · ownership attribution and instrument terms
F1: 2019 PSUs (PP18) award vesting net of taxes withheld. The net shares were deferred as deferred stock units in the Non-Qualified Deferred Compensation (NQDC) plan for employees to be distributed in accordance with the terms of the NQDC plan and their individual elections
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2022 Filed Feb 25, 2022 02:25 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 3,597 | $369.13 | $1,327,760.61 |
DisclosureSEC source: 0001562180-22-001906 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,731.42 F1 · shares: 2019 PSUs (PP18) award vesting net of taxes withheld. The net shares were deferred as deferred stock units in the Non-Qualified Deferred Compensation (NQDC) plan for employees to be distributed in accordance with the terms of the NQDC plan and their individual elections Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:54 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 2,848 | $0.00 Strike: $369.13 | $0.00 |
DisclosureSEC source: 0001562180-22-001880 · primarydocument.xml · derivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,848 Underlying: Stock Options (Right to Buy) · 2,848 shares Expires 2032-02-22 F1 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 22, 2023. Read SEC document |
| February 13, 2022 Filed Feb 14, 2022 22:24 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 27 | $391.20 | $10,562.40 |
DisclosureSEC source: 0001562180-22-001454 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,134.42 F1 · shares: Shares withheld to cover taxes related to Bonus and incentive shares granted on February 13, 2018. Read SEC document |
| September 26, 2021 Filed Sep 27, 2021 20:59 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 620 | $457.11 | $283,408.20 |
DisclosureSEC source: 0001562180-21-006112 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,161.42 F1 · kind: Shares withheld solely for the purpose of satisfying tax liability due upon vesting of restricted stock award. Read SEC document |
| February 23, 2021 Filed Feb 25, 2021 22:47 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 4,364 | $0.00 Strike: $274.29 | $0.00 |
DisclosureSEC source: 0001562180-21-001594 · primarydocument.xml · derivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,364 Underlying: Common Stock · 4,364 shares Expires 2031-02-23 F1 · derivative.exercise_date: This award vests in 4 equal annual installments beginning on 2/23/2022. Read SEC document |
| February 22, 2021 Filed Feb 24, 2021 22:33 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 4,481 | $272.65 | $1,221,744.65 |
DisclosureSEC source: 0001562180-21-001574 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,781.42 F1 · shares: 2018 PSUs (PP17) award vesting net of taxes withheld Read SEC document |
| February 14, 2021 Filed Feb 17, 2021 17:27 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Tax withholdingCommon Stock | 9 | $294.01 | $2,646.09 |
DisclosureSEC source: 0001562180-21-001186 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,300.42 F1 · shares: Shares withheld to cover taxes related to Bonus and incentive shares granted on February 14, 2017. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to buy) · Derivative | 5,358 | $0.00 Strike: $83.47 | $0.00 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · derivative · entry 12 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,786 Underlying: Common Stock · 5,358 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 3,273 | $270.70 | $886,013.54 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 9 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,309.42 Read SEC document |
| July 29, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 5,358 | $83.47 | $447,232.26 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 8 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,582.42 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Options (Right to buy) · Derivative | 3,000 | $0.00 Strike: $83.47 | $0.00 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · derivative · entry 11 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,144 Underlying: Common Stock · 3,000 shares Expires 2027-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,792 | $0.00 Strike: $71.79 | $0.00 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · derivative · entry 10 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,792 shares Expires 2026-09-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 3,000 | $265.98 | $797,930.70 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 7 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,224.42 F4 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.9762 to $265.9769, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 138 | $265.85 | $36,687.40 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 6 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,224.42 F3 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $265.80 to $265.87, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 2,881 | $265.13 | $763,837.23 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 5 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,362.42 F2 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $264.80 to $265.77, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 7,773 | $264.13 | $2,053,094.15 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 4 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,243.42 F1 · price: The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $263.80 to $264.79, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | SaleCommon Stock | 716 | $266.06 | $190,497.53 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 3 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,016.42 Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 3,000 | $83.47 | $250,410.00 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 2 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,732.42 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 28, 2020 Filed Jul 30, 2020 22:22 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | Exercise / conversionCommon Stock | 10,792 | $71.79 | $774,757.68 |
DisclosureSEC source: 0001562180-20-005231 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,732.42 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 13, 2020 13:45 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 373 | $156.49 | $58,370.77 |
DisclosureSEC source: 0001562180-20-002456 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,940.42 F1 · shares: Portion of bonus paid in stock Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:08 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to Buy) · Derivative | 6,376 | $0.00 Strike: $173.22 | $0.00 |
DisclosureSEC source: 0001562180-20-001427 · primarydocument.xml · derivative · entry 2 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,376 Underlying: Common Stock · 6,376 shares Expires 2030-02-18 F2 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 18, 2021. Read SEC document |
| February 18, 2020 Filed Feb 21, 2020 01:08 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,419 | $173.22 | $245,799.18 |
DisclosureSEC source: 0001562180-20-001427 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,567.42 F1 · shares: 2017 PSUs (PP16) award vesting. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 20:01 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 526 | $106.14 | $55,829.64 |
DisclosureSEC source: 0001562180-19-001638 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,148.42 F1 · shares: Bonus & Incentive share grant Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:12 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 8,160 | $102.51 Strike: $102.51 | $836,481.60 |
DisclosureSEC source: 0001562180-19-001221 · primarydocument.xml · derivative · entry 2 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,160 Underlying: Common Stock · 8,160 shares Expires 2029-02-19 F2 · derivative.exercise_date: This award vests in four equal annual installments beginning on February 19, 2020. Read SEC document |
| February 19, 2019 Filed Feb 22, 2019 00:12 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 716 | $102.51 | $73,397.16 |
DisclosureSEC source: 0001562180-19-001221 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,622.42 F1 · shares: 2016 PSUs (PP15) award vesting. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:39 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 20,052 | $89.64 Strike: $89.64 | $1,797,461.28 |
DisclosureSEC source: 0001562180-18-001150 · primarydocument.xml · derivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,052 Underlying: Common Stock · 20,052 shares Expires 2028-02-20 F1 · derivative.exercise_date: This award vests in 4 equal annual installments beginning on 2/20/2019 Read SEC document |
| February 13, 2018 Filed Feb 15, 2018 22:32 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 386 | $93.00 | $35,898.00 |
DisclosureSEC source: 0001562180-18-001008 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,906.42 Read SEC document |
| February 21, 2017 Filed Feb 22, 2017 20:20 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Options (Right to buy) · Derivative | 11,144 | $83.47 Strike: $83.47 | $930,189.68 |
DisclosureSEC source: 0001562180-17-000851 · primarydocument.xml · derivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,144 Underlying: Common Stock · 11,144 shares Expires 2027-02-21 F1 · derivative.exercise_date: This award vests in 4 equal annual installments beginning on 2/21/2018. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 00:03 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 125 | $86.93 | $10,866.25 |
DisclosureSEC source: 0001562180-17-000714 · primarydocument.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,520.42 F1 · shares: Bonus and incentive shares granted on 02/14/2017. F2 · balance_after: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement. Read SEC document |
| September 26, 2016 Filed Sep 28, 2016 19:35 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantStock Option (Right to Buy) · Derivative | 10,792 | $71.79 Strike: $71.79 | $774,757.68 |
DisclosureSEC source: 0001225208-16-039736 · doc4.xml · derivative · entry 2 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,792 Underlying: Common Stock · 10,792 shares Expires 2026-09-26 F2 · derivative.exercise_date: This award vests in 4 equal installments beginning on 2/23/2017. Read SEC document |
| September 26, 2016 Filed Sep 28, 2016 19:35 UTC | WEST PHARMACEUTICAL SERVICES INC WST · Entity 3201 | GrantCommon Stock | 1,393 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039736 · doc4.xml · nonDerivative · entry 1 MONTECALVO DAVID A · CIK 0001241973 · SVP, Glob Ops and Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,393 F1 · shares: This award vests on 9/26/2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.